Brodalumab Injection and Finerenone: Interaction Details

Brand names
Brodalumab Injection
Siliq
Finerenone
Kerendia
Same medicines, other forms
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page

A close look at the Brodalumab Injection and Finerenone interaction:

Share

Share this interaction

What Happens When You Take Brodalumab Injection With Finerenone

What can happen when they are taken together (rated Major)

Increased finerenone exposure and an increased risk of finerenone-related adverse effects

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Finerenone is a , and coadministering it with a moderate or weak CYP3A4 may raise the likelihood of finerenone adverse reactions. With erythromycin, a moderate CYP3A4 inhibitor, finerenone mean rose by 248% and mean by 88%.

Verapamil, likewise a moderate CYP3A4 inhibitor, raised finerenone mean AUC by 170% and mean Cmax by 122%. Amiodarone, classified as a weak CYP3A4 inhibitor, produced a 21% rise in finerenone AUC.1 When the two are given together, serum potassium should be monitored whenever either finerenone or the moderate or weak CYP3A4 inhibitor is started or has its dose changed, with the finerenone dose modified as appropriate.

The Brodalumab Injection and Finerenone Interaction, Explained

Brodalumab (Siliq) is a shot for psoriasis that calms an overactive immune system. Finerenone (Kerendia) helps protect the kidneys and heart in people with diabetes-related kidney disease. Our interaction records note that brodalumab may cause finerenone to build up in your body. More finerenone can raise the chance of side effects, especially a high potassium level, which can cause muscle weakness, an irregular heartbeat, or feeling very tired.

The good news is that your care team can manage this. They may check your potassium with a simple blood test, and your finerenone dose may need to be adjusted and individualized. Keep taking both as prescribed and talk with your pharmacist or doctor.

Mechanism/direction: Documented as reduced -mediated of finerenone (a CYP3A4 ), increasing exposure. For brodalumab, an anti-IL-17RA monoclonal antibody, any effect on CYP3A4 is indirect (cytokine-mediated modulation of expression) rather than direct enzyme , so magnitude is not well defined. Reference data with moderate CYP3A4 : erythromycin increased finerenone 248%, 88%; verapamil increased AUC 170%, Cmax 122%; amiodarone (weak) increased AUC 21%.

  • Severity: major; evidence: probable; onset: unspecified.
  • Risk: , .
  • Management: monitor serum potassium at initiation or dose change of either agent; titrate finerenone as appropriate.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Brodalumab Injection and Finerenone Interact

The likely mechanism

of -mediated of finerenone

In short: Brodalumab injection slows CYP3A4, an enzyme that breaks down finerenone, so finerenone can build up in the body.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When One Drug Raises Another’s Level”, one chapter of our one-minute explainer. See how it works 

How to Manage the Brodalumab Injection and Finerenone Interaction

This combination can be managed safely with some extra attention.

  • What your care team may do: check your potassium level when either medicine is started or its dose is changed, and adjust your finerenone dose based on those results.
  • What you can do: keep taking both medicines exactly as prescribed. Make sure every prescriber and your pharmacist knows you use both.
  • Tell your care team promptly if you notice muscle weakness, an unusual or irregular heartbeat, or dizziness.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Brodalumab Injection or Finerenone need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: KERENDIA oral tablets, finerenone oral tablets

    When finerenone was given together with erythromycin (a moderate ), its mean rose by 248% and its mean by 88%. with verapamil (a moderate CYP3A4 inhibitor) raised finerenone mean AUC by 170% and mean Cmax by 122%. Coadministration with amiodarone (a weak CYP3A4 inhibitor) raised finerenone AUC by 21%.1

Brodalumab Injection and Finerenone: Common Questions

How serious is the Brodalumab Injection and Finerenone interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Brodalumab Injection and Finerenone interaction managed?

This combination can be managed safely with some extra attention. What your care team may do: check your potassium level when either medicine is started or its dose is changed, and adjust your finerenone dose based on those results. What you can do: keep taking both medicines exactly as prescribed. Make sure every prescriber and your pharmacist knows you use both. Tell your care team promptly if y… Management is individual — always follow your own care team's guidance.

Does taking Brodalumab Injection and Finerenone at different times of day help?

No. Taking them at different times of day does not prevent this one. Brodalumab injection slows , an enzyme that breaks down finerenone, so finerenone can build up in the body. That change lasts while brodalumab injection is being taken and can continue for a while after the last dose.

Your pharmacist or prescriber can tell you how they will manage it.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Brodalumab Injection and Finerenone Interaction

Ask in your own words about taking Brodalumab Injection and Finerenone together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: KERENDIA(R) oral tablets, finerenone oral tablets. Bayer HealthCare Pharmaceuticals Inc (per FDA), Whippany, NJ, 2025. DailyMed
Was this write-up helpful?

Other Serious Interactions of Brodalumab Injection and Finerenone

Also serious with Brodalumab Injection

Also serious with Finerenone

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Finerenone

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.